Here are five key points:
1. The market was valued at $12.6 billion in 2016.
2. The global spinal and neurostimulation intervention products market will continue to grow at a compound annual growth rate of 4.5 percent through 2021.
3. The market’s largest segment is spine surgery, which is expected to increase from $9 billion in 2016 to $10.8 billion in 2021.
4. The market’s spine surgery segment will continue to grow at a CAGR of 3.5 percent.
5. The neurostimulation devices segment will likely reach $5 billion in 2021, growing at a CAGR of 6.9 percent throughout the forecast period.
More articles on devices:
House introduces bill to permanently repeal medical device tax: 4 things to know
Titan Medical names David McNally new CEO — 7 key points
NuVasive receives approval to continue XLIF procedures in Japan— 6 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
